HB 1948, Prescription Monitoring Program (PMP) goes into effect November 1, 2015. The legislation clarifies language related to the Uniform Controlled Dangerous Substance Act and establishes a Prescription Monitoring Program for all prescribers: osteopathic and allopathic physicians, dentists, veterinarians, optometrists, nurses, and podiatrists. The bill requires these prescribers to access the PMP “prior to prescribing or authorizing for refill if 180 days have elapsed prior to the previous access and check, of opiates, synthetic opiates, semisynthetic opiates, benzodiazepine, or carisoprodol to a patient of record”.
HB 1948 grants the sole responsibility for enforcement of the patient screening requirements to the licensing entity for each profession subject to the Act and a listing of the top 20 prescribers of controlled dangerous substances will be sent to their licensing entity. Click here to view the Oklahoma Hospital Association post including FAQs. Click here to view HB 1948.